{
  "id": 20371307,
  "title": "Ambiq Micro CEO Esaka disposes of $5.28 million in shares",
  "url": "https://urgent.news/2026/11/17/ambiq-micro-ceo-esaka-disposes-of-5-28-million-in-shares",
  "topic": "finance",
  "section": "Finance & Markets",
  "published": "2026-11-17T02:46:19.000Z",
  "source": {
    "name": "Investing.com",
    "slug": "investing-com",
    "url": "https://www.investing.com/news/insider-trading-news/ambiq-micro-ceo-esaka-disposes-of-528-million-in-shares-93CH-5031513"
  },
  "original_language": "en",
  "account": "Fumihide Esaka, the Chief Executive Officer and Director at Ambiq Micro, Inc. (NASDAQ:AMBQ), recently sold a substantial amount of shares, totaling approximately $5.28 million. These transactions took place between November 12 and November 16, 2026. The sales were a result of exercising stock options, which allowed him to purchase an equal number of shares at a cost of around $1.36 million. The stock's current price is $44.03, having decreased by 37.6% over the past six months, yet it has still risen by 81.5% over the past year. Ambiq Micro's market capitalization stands at $1.1 billion. On the specified dates, Esaka sold 104,821 shares, generating roughly $5.06 million from prices between $45.45 and $51.45 per share. Investment analysis suggests that Ambiq Micro may be overvalued at present, making it a feature on the platform's Most Overvalued list. For a more comprehensive understanding, investors can consult the Pro Research Report, which covers AMBQ and a multitude of other US equities. Additionally, on November 16, Esaka sold 5,000 shares for approximately $220,458, with prices ranging from $43.92 to $44.43 per share. These specific sales were executed under a trading plan initiated on May 15, 2026. Esaka acquired these shares through option exercise at prices of $12.60 and $8.12 per share, respectively, totaling approximately $1.32 million and $40,599. In other recent developments, Ambiq Micro reported its Q3 fiscal 2026 earnings, demonstrating a remarkable 110% increase in revenue to $38.14 million, and narrowing its adjusted loss per share to $0.05. The company's gross margin improved to 48.7%, and it concluded the quarter with $363.5 million in cash and no debt. Despite the positive outlook, with analysts lowering their price target to $70 from $85 while maintaining a Buy rating, some investors remain cautious due to ongoing supply constraints.",
  "summary": null,
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}